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Abstract
Background: In recent years, several lines of evidence have shown an increase in Parkinson’s disease prevalence in
rural environments where pesticides are heavily used. Although, the underlying mechanism for neuronal
degeneration in sporadic PD remains unknown, mitochondrial dysfunction, oxidative stress and proteasomal
dysfunction are proposed as contributing factors. In this study rats were chronically and continuously exposed to
the pesticide, dichlorvos to identify the molecular mechanism of nigrostaital neuronal degeneration.
Result: Chronic dichlorvos exposure (2.50 mg/kg b.wt.s.c/daily for 12 weeks) caused nigrostriatal dopaminergic
degeneration. The degenerative changes were accompanied by a loss of 60-80% of the nigral dopamine neurons
and 60-70% reduction in striatal dopamine and tyrosine hydroxylase levels. Dichlorvos exposed animals also
showed a -synuclein and ubiquitin positive inclusions along with swollen, dystrophic neurites and mitochondrial
abnormalities like decreased complex I&IV activities, increased mitochondrial size, axonal degeneration and
presence of electron dense perinuclear cytoplasmic inclusions in the substantia nigra of rats. These animals also
showed evidence of oxidative stress, including increased mitochondrial ROS levels, decreased MnSOD activity and
increased lipid peroxidation. Measurable impairments in neurobehavioral indices were also observed. Notable
exacerbations in motor impairments, open field and catalepsy were also evident in dichlorvos exposed animals.
Conclusion: All these findings taken together indicate that chronic dichlorvos exposure may cause nigrostaital
neurodegenaration and significant behavioral impairments.
Background
Parkinson’s disease (PD) is a common neurodegenerative
disease characterized by disabling motor abnormalities,
which include tremors, muscle stiffness, paucity of volun-
tary movements, and postural instability [1]. Its main
neuropathological feature is the loss of the nigrostriatal
dopamine containing neurons, whose cell bodies are in
the substantia nigra pars compacta (SNpc) and nerve
terminals in the striatum. Epidemiological studies indi-
cate that pesticides are one of the leading candidates of
environmental toxins that may contribute to the patho-
g e n e s i so fP D[ 2 , 3 ] .R e p o r t sof parkinsonism following
pesticide exposure [4-6] make pesticide-induced parkin-
sonism biologically plausible. Hertzman et al [4] found a
significant association between PD and an occupation of
handling pesticides in British Columbia. PD is most pre-
valent in industrialized countries [7]. For example in
China, the ubiquity of PD is much lower as compared to
t h em o r ei n d u s t r i a l i z e dU S A .H o w e v e r ,e v e ni nC h i n a ,
PD appears to be associated with exposure to industrial
chemicals [7]. For example in China, the ubiquity of PD
is much lower as compared to the more industrialized
USA [6]. However, even in China, PD appears to be asso-
ciated with exposure to industrial effluents [7], as
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viously exposed to herbicides/pesticides had a 3.6-fold
increased risk of developing PD in Hong Kong.
Although, the underlying mechanism for neuronal
degeneration in sporadic PD remains unknown, mito-
chondrial dysfunction, oxidative stress and proteasomal
dysfunction are proposed as contributing factors. Rote-
none, a common pesticide and an inhibitor of mitochon-
drial complex I, has been shown to induce Parkinsonian
features in rats [3]. Other pesticides, such as paraquat
and dieldrin, have also been reported to cause degenera-
tion of dopaminergic neurons [9]. The mechanisms how-
ever, remain largely unknown. Although, the majority of
PD patients have sporadic onset and do not have a famil-
ial history, genetic findings have provided important
insights into pathogenic mechanisms of PD [10]. The
causes of this disease still remain to be elucidated.
Understanding the cause of PD is critical as that knowl-
edge could lead to directed research that will develop
potent therapies. The relative contributions of genetic
versus environmental factors regarding the cause of PD
have been hotly debated. In this contest, we thought of
exposing rats chronically and continuously to the pesti-
cide dichlorvos (DDVP) which is one of the most com-
monly used organophosphate (OP) pesticide in India and
studying its mechanism of action. It has been commer-
cially manufactured and used throughout the world. It is
also an inhibitor of complex I, one of the five enzyme
complexes of the inner mitochondrial membrane [11].
Because of its extremely hydrophobic nature, it crosses
biological membranes easily, and it does not depend on
the dopamine transporter for access to the cytoplasm.
Recently, different environmental toxins have been inves-
tigated that take into account epidemiological and envir-
onmental risk factors for PD. In this study, one basic
question asked was whether nigrostriatal neuronal degen-
eration and Lewy body formation are produced after
chronic low level dichlorvos exposure? And if yes, what
are its consequences? In addition, the relevance of mito-
chondrial dysfunctions to potential involvement of
chronic low level dichlorvos exposure leading to beha-
vioral changes was also kept in mind. At the end of the
study we found that, chronic dichlorvos exposure causes
marked nigrostriatal neuronal degeneration along with
Lewy body formation and mitochondrial impairments
leading to behavioral changes in rats.
Result
Male albino rats (Wistar strain) were administrated
dichlorvos (2.5 mg/kg, sc. dissolved in corn oil over a
period of 12 weeks systemically on a daily basis). In this
study, pulsatile administration was chosen because it is
more close to exposure in normal life, such as via inha-
lation, dermal contact, and the oral ingestion of
pesticide residues, via foods such as vegetables, fruits
and fish. High doses of dichlorvos for short periods of
time produced systemic (cardiovascular and liver) toxi-
city and non-specific brain lesions, as reported earlier
from our lab and others [11-14]. Downward titration of
dichlorvos dosing resulted in less systemic illness and
dopaminergic degeneration. We wanted to choose a low
dose of dichlorvos, which is similar to human exposure
especially in rural areas where pesticides are in more
use, and also factories where pesticides are manufac-
tured. As far as rural area and pesticide factories are
concerned persons working there are exposed to pesti-
cides slowly at lower doses and for long durations.
Three month exposure of dichlorvos to rats is equiva-
lent to approximately seven and half years of human
exposure. At this very dose regime it was observed that
acetylcholine esterase activity was not inhibited and no
signs of systemic toxicity were observed in these
animals.
Studies on the effect of dichlorvos induced mitochondrial
impairments on dopaminergic system in substantia nigra
and corpus striatum of rat brain
Mitochondrial dysfunction has also been linked to PD.
Specifically, there are systemic reductions in the activity
of complex I and 1V of the mitochondrial ETC in PD
brain, muscle and additional evidence for mitochondrial
impairment in PD comes from the finding that MPP,
the active metabolite of the parkinsonism toxin MPTP,
acts as a complex I inhibitor. Therefore, it was pertinent
to investigate the different aspects of mitochondrial
energy metabolism in vivo i nt h ew a k eo fc h r o n i c
dichlorvos exposure in different rat brain regions (SN
and CS).
Effect of chronic dichlorvos exposure on NADH
dehydrogenase activity in substantia nigra and corpus
striatum of rat brain
NADH dehydrogenase or complex I is a membrane
bound enzyme, which catalyzes the transfer of two elec-
trons from NADH to ubiquinone in a reaction that is
associated with proton translocation across the mem-
brane. Any alteration in the activity of NADH dehydro-
genase may disturb the in flow of electrons through
various electron carriers in the electron transport chain.
Therefore, the activity of NADH dehydrogenase was
assessed in rat brain mitochondria following chronic
dichlorvos exposure. It is clear from Figure 1A, that
there was a significant decrease in the activity of NADH
dehydrogenase in both the regions of rat brain following
chronic dichlorvos administration. Brain mitochondrial
NADH dehydrogenase activity was decreased by 62% in
SN followed by CS (70.2%) in dichlorvos treated animals
as compared to controls (Figure 1A).
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oxidase activity in substantia nigra and corpus striatum
of rat brain
Cytochrome oxidase (Complex IV) is the terminal enzyme
of the mitochondrial electron transport chain and is
responsible for the reduction of molecular oxygen, which
is linked to ATP production. In view of this, the activity of
cytochrome oxidase was assayed in rat brain mitochondria.
Cytochrome oxidase activity was decreased by 56.7%, in
SN of dichlorvos treated animals as compared to controls
(Figure 1B). Further, the mitochondria isolated from CS of
rat brain showed 55.4% decrease in the activity of complex
IV following 12 weeks of dichlorvos exposure (Figure 1B).
This decrease was found to be highly significant in both
the regions (p < 0.001) of treated rat brain mitochondria.
The decrease in the activity of cytochrome oxidase could
be responsible for the ability of dichlorvos to interfere
with oxygen metabolism and the possible generation of
the state of cellular hypoxia as well as in the production of
oxygen free radicals.
It appears that dichlorvos consistent with its ability to
cross biological membranes because of its lipophilicity
had a significant detrimental effect on complex 1 and IV
which are embedded in the mitochondrial membrane.
Effect of dichlorvos on Mitochondrial ROS levels in
substantia nigra and corpus striatum of rat brain
Mitochondria are the major cellular source of intracellu-
lar ROS. In our study it was observed that dichlorvos
inhibited Complex I and IV activities, and therefore it
may also result in enhanced ROS production. Therefore
ROS levels were measured using the dye 2,7-dichloro-
fluorescein diacetate. As compared to controls, the
mitochondria isolated from the brains (SN and CS
regions) of dichlorvos exposed animals showed signifi-
cant increase (p < 0.001) in signal fluorescence suggest-
ing higher ROS accumulation in mitochondria of these
regions (Figure 1C). Our results suggest that increased
rate of H2DCF oxidation be interpreted as an indication
of general oxidative stress due to a variety of reasons,
including depletion of antioxidants, rather than as a spe-
cific proof of augmented ROS formation.
These results further substantiate the findings that
chronic dichlorvos exposure leads to mitochondrial dys-
function by acting at Complex 1 and IV of electron
transport chain. These impairments of mitochondrial
functions may be involved in the generation of ROS and
hence a state of oxidative stress.
Effect of dichlorvos on Lipid peroxidation in substantia
nigra and corpus striatum of rat brain
Oxidative stress has been considered as an important
factor in the pathogenesis of PD. To study the potential
involvement of oxidative stress in dichlorvos neurotoxi-
city, we measured lipid peroxidation by measuring MDA
accumulation. It was significantly increased in the SN
and CS after chronic dichlorvos treatment (Figure 1D).
In SN lipid peroxidation levels were 50.29% higher as
Figure 1 Effect of chronic dichlorvos exposure on mitochondrial electron transport chain.(A) NADH dehydrogenase activity. (B)
Cytochrome oxidase activity. (C) ROS levels. (D) Lipid peroxidation. Dichlorvos treated rats received 2.5 mg/kg b.wt of dichlorvos, sc., for 12
weeks and control animals received equal volume of corn oil. The values are mean ± S.D. of 6 animals in each group. *** p < 0.001 significantly
different from control group.SN: substantia nigra; CS: corpus striatum.
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of dichlorvos exposed animal, 38% increased lipid perox-
idation was observed when compared to control CS
region.
Effect of chronic dichlorvos exposure on Mn SOD activity
in substantia nigra and corpus striatum of rat brain
Mitochondria are the main intracellular source of free
radical generation. Superoxide dismutase (SOD) is pre-
sent in all aerobic cells. MnSOD an isoform of SOD, is
exclusively mitochondrial in origin and functions to facil-
itate the dismutation of superoxide radicals to H2O2.
Results of SOD activity are shown in additional file 1.
The mean MnSOD activity was 25.78 ± 5.27 U/mg pro-
tein and 30.08 + 5.2 U/mg protein in SN and CS respec-
tively in the control animals. Where as MnSOD activity
in the animals treated with dichlorvos (SN 10.5 + 3.5 and
CS 15.94 + 3.67), showed statistically significant decrease
(after 12 weeks). A decreased MnSOD activity reveals a
state of oxidative stress in the mitochondria of dichlorvos
exposed rats.
Effect of chronic dichlorvos exposure on ATP Levels in
substantia nigra and corpus striatum of rat brain
As the primary energy source of most cells, ATP gen-
eration is essential to cell survival; impairment of mito-
chondrial respiration implies the reduced availability of
ATP for maintaining essential cellular processes. As we
had observed inhibition of respiratory complexes as well
as MnSOD and increased generation of ROS and lipid
peroxidation, it was imperative to estimate the ATP
levels so as to assess the energy status of the cell.
The ATP levels in brain mitochondria were estimated
following chronic dichlorvos exposure. As evident from
Figure 2A, the ATP levels declined significantly in dif-
ferent regions of dichlorvos treated rats. The level of
ATP decreased by 60.8% in SN of treated group, por-
traying altered mitochondrial metabolism in this region.
The decrease in ATP levels in the other region viz CS
was 49%. This observation suggested that cells exposed
to dichlorvos suffered from energy deficit and a state of
chronic persistent energy crisis might have been
generated.
Studies on the ultra structural changes of mitochondria in
SN and CS neurons after chronic dichlorvos exposure
Mitochondrial abnormalities in the SN after chronic
dichlorvos exposure
Electron microscopic studies were carried out in order
to know if the biochemical changes observed after
dichlorvos exposure were strong enough to leave an
impact on the morphology of mitochondria from SN
and CS from control and treated groups. Striking
changes in the mitochondria of neurons and neuropil of
the SN in dichlorvos exposed rats (Figures 3B, C, 4A)
were observed. These changes were not observed in the
control group. In the dichlorvos exposed rats, many
mitochondria in the neuropil of the SN were greatly
enlarged and swollen into spherical shapes rather than
the normal ovoid or rod shape (Figures 3B, C, 4A, B).
Frequently, these enlarged mitochondria had prominent
distorted cristae (thick arrow 3B, C). To look at the dif-
ferences in mitochondrial structure between two groups
quantitatively, we systematically measured two mito-
chondrial parameters that reflected size and shape, the
cross-sectional area and perimeter for each mitochon-
drion (Figure 4A) in a blinded fashion. The mean cross-
sectional area per mitochondrion for the dichlorvos
group was 1,079,363 nm
2, compared to152, 302 nm
2,
controls. By T test and Mann-Whitney test the means
were found to be significantly different (P < 0.001). The
mean perimeter length per mitochondrion for the
dichlorvos group was 4514.365 nm, compared to
1647.206 control group. T test analysis for mitochon-
drial perimeter length also resulted in identical increase
as that for cross sectional area of mitochondrial (means
were significantly different by t test at P < 0.001),
(Figure 4A).
In the SN of dichlorvos treated animals, we found
spherical inclusions in the perinuclear cytoplasm of a few
neurons (Figure 4B). No aggregates or inclusions were
f o u n di nc o n t r o la n i m a l .I na d d i t i o n ,c h r o m a t i nc o n d e n -
sation was also seen in the dichlorvos treated animals
( F i g u r e3 A ) .M a n yS Nn e u r o n sin the dichlorvos treated
group also appeared shrunken with reduced cytoplasmic
volume and had nuclei with deep invaginations of the
nuclear membrane (Figure 3A). Similar losses of cyto-
plasmic volume or invaginations of the nuclear mem-
brane were not found in neurons from the control group.
Effect of chronic dichlorvos exposure on Tyrosine
hydroxylase activity in substantia nigra and corpus
striatum of rat brain
Tyrosine hydroxylase is the rate limiting enzyme in cate-
cholamine biosynthesis. It functions as an oxidoreduc-
tase and tetrahydrobiopterin acts as a co-factor to
convert L-tyrosine to L-DOPA (L-dihydroxyphenylala-
nine). More over tyrosine hydroxylase is a marker for
dopamine neurons. As is evident from Figure 2B,
chronic administration of dichlorvos causes significant
decrease in the TH enzyme activity in SN and CS as
compared to control. Dichlorvos treated animals showed
TH enzyme activity reduced to 52.33% in SN and
50.85% in CS compared to control animals. This sug-
gests that dichlorvos could decrease dopamine levels by
decreasing the tyrosine hydroxylase activity.
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Dopamine and its metabolites in SN and CS of rat brain
The impact of dichlorvos exposure on DA synthesis and
storage was assessed in tissue samples from CS and SN.
Chronic s.c injection of dichlorvos produced significant
loss of dopamine in the SN and CS following 12 week of
administration. The level of dopamine decreased by 73%
in SN and 76.8% in CS respectively compared to control
animals (Figure 2C). In addition to dopamine, it’sm e t a -
bolites levels were also significantly decreased. Dichlorvos
treated animals showed 72.5% (SN) and 44.23% (CS)
reduction in the levels of DOPAC compared to control
animals (Figure 2D). In the case of HVA, dichlorvos trea-
ted animal showed 72.5% (SN) and 44% (CS) reduction
when compared to controls (Figure 2E). These results
indicate that dichlorvos administration may cause signifi-
cant decrease in the levels of dopamine and its metabo-
lites in SN and CS region of rat brain.
Effect of chronic dichlorvos exposure on Dopamine
-b- hydroxylase activity in substantia nigra and corpus
striatum of rat brain
Dopamine-b-hydroxylase is a mixed function oxidase
which catalyses the conversion of dopamine to norepi-
nephrine and it is also a marker for noradrenergic neu-
rons. No change in the activity of DBH was observed in
any of the brain regions studied after chronic dichlorvos
e x p o s u r e .S oi ts e e m st h i sd o s eo fd i c h l o r v o si sn o t
toxic to noradrenergic neurons but specifically affects
dopaminergic neurons (Additional file 2).
Effect of chronic dichlorvos exposure on Monoamine
Oxidase A activity in substantia nigra and corpus striatum
of rat brain
Monoamine oxidase is catecholamine degradative
enzyme which deaminates dopamine and norepinephr-
ine to their corresponding aldehydes. Monoamine oxi-
dase A specifically deaminates dopamine. As shown in
additional file 3, no significant change in the Monoa-
mine oxidase enzyme activity was observed in any of the
brain regions studied after chronic dichlorvos adminis-
tration as compared to control. This indicates that
chronic dichlorvos exposure is not affecting the degra-
dative pathway. The decrease in the levels of dopamine
m a yb ed u et ot h ed e c r e a s e da c t i v i t yo fT He n z y m e
responsible for its synthesis.
Effect of chronic dichlorvos exposure on the activity of
acetylcholinesterase in rats
Acetylcholinesterase, which is the degradative enzyme of
acetylcholine and thereby responsible for the termination
of cholinergic response, exists as true (acetyl) cholinester-
ase and pseudo (butyryl) cholinesterase. The true choli-
nesterase is the functional enzyme of the cholinergic
Figure 2 Effect of chronic dichlorvos exposure on ATP levels, Tyrosine hydroxylase activity, Dopamine and its metabolites in SN and CS
of rat brain. (A) ATP levels. (B). Tyrosine hydroxylase activity (C). Dopamine levels. (D) DOPAC levels. (E) HVA levels. The values are mean ± S.D. of 6
animals in each group. *** p < 0.001 significantly different from control group. SN: substantia nigra; CS: corpus striatum.
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in brain. Following chronic (2.5 mg/kg b.wt./day for 12
weeks, sc) dichlorvos exposure it was observed that there
was no significant decrease (Additional file 4) in the
activity of brain acetyl cholinesterase in treated rats as
compared to controls. So, at this dose regime cholinergic
neurons are not affected.
General behavioral, motor impairments and catalepsy
behavior
Having observed dopamine depletion after chronic
dichlorvos administration in SN and CS of rat brain, it
was imperative to assess motor functions, open field and
catalepsy as these are known to be affected by dopamine
levels.
Open field
Locomotor activity refers to the movement from one
location to another. In rodents, one of the most impor-
tant component of exploration, a prominent activity of
the rat’s repertoire of spontaneous activity, is locomo-
tion. Moreover, locomotor activity and exploration are
involved in many behavioral and physiological functions.
The Open Field test is commonly used to assess loco-
motor behavior. Furthermore, locomotor abnormalities
are associated with several human diseases such as
Figure 3 Transmission electron micrograph of SN of rat brain regions showing the ultra structural changes of nucleus after chronic
dichlorvos exposure.(A), Chromatin condensation and reduced cytoplasmic volume were observed in SN. Scale bars - 500 nm. (B&C) Relatively
normal appearance of perinuclear cytoplasmic contents including mitochondria, endoplasmic reticulum and Golgi apparatus in control group.
Dichlorvos exposed animals showed mitochondrial enlargement with more distorted cristae (thick arrow head) in the surrounding neuropil of
neurons. CSN: substantia nigra; CCS: corpus striatum;DSN: Dichlorvos substantia nigra;DCS: Dichlorvos corpus striatum. Scale bar: 500 nm.
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syndrome and are also displayed by animal models.
Hence, we studied the open field behavioral functions
after chronic dichlorvos exposure.
Rats were tested for behavioral activity six weeks and
twelve weeks after dichlorvos administration. Figure 5
illustrates the effect of chronic dichlorvos administration
to rats on the locomotor activity in the open field. Six
weeks after chronic dichlorvos administration, rats exhib-
ited a decrease in locomotor activity which was more sig-
nificant at 12 weeks of dichlorvos exposure. Not only
locomotor activity, but the other components of open
field like total distance travelled, immobile time and
rearing were also affected at 6 and 12 weeks of post
exposure and the alterations were more pronounced at
12 weeks post exposure when compared to control
(Figure 5A-C).
Rearing and ambulation were also observed by Acto-
photometer. Again there was significant difference
between control and treated animals as depicted in Fig-
ure 5D after12 weeks of exposure.
Motor function test
PD patients show increasing motor impairment, gait and
postural difficulties and cognitive dysfunction. In addi-
tion to this, different PD animal models also show signifi-
cant motor impairments. So, we were interested to know
Figure 4 (A) Analysis of mitochondrial perimeter length and cross-sectional area in the neuropil of the Substantia nigra. Both the
cross-sectional area/mitochondrion and perimeter length/mitochondrion for the dichlorvos group were significantly greater than the control
group. (B) Ultra structure of SN neurons from dichlorvos treated rat brain containing perinuclear cytoplasmic inclusions. Scale bars: 500 nm (thin
arrowhead perinuclear inclusions). CSN; Substantia nigra DSN: Dichlorvos Substantia nigra.
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affected after chronic dichlorvos administration or not?
Rota rod performance
The rota rod test was carried out to assess the muscle
strength and motor impairments of animals following
chronic dichlorvos administration.
T h er o t ar o dt e s t( F i g u r e5 E )r e v e a l e dam a r k e d
impairment in the muscle strength and coordination.
There was a significant (p < 0.05) reduction in the
retention time at 6 week and 12 week. The treated ani-
mals showed neuromuscular incoordination and seemed
totally disorientated and confused during the training
period as compared to control animal. None of the trea-
ted animals could maintain themselves on the rotating
rod for the full quota of the cut off time (180 s).
Chronic dichlorvos administration and catalepsy
Catalepsy in laboratory animals is defined as a failure to
correct an externally imposed posture. When a normal
animal is placed in an unusual posture, it will change its
position within seconds. A cataleptic animal, on the other
hand, will maintain this posture for a prolonged period of
time (i.e., several minutes or longer). Catalepsy was of
interest to us because of its similarity to symptoms of such
human disorders as Parkinsonism and brain damage invol-
ving parts of the basal ganglia.
Cataleptic scores of the present study are given in addi-
tional file 5a&b, assessed by block method and metal bar
test, respectively. Dichlorvos administered animals showed
significant increased cataleptic scores in block test. Bar
test also showed the same result. Dichlorvos administra-
tion lead to progressive and significantl development of
catalepsy (p < 0.01) at a dose of 2.5 mg/kg after 6
th week
and 12
th week. However, there was no pronounced
increase in the cataleptic scores in control animals after 12
weeks. The maximal increase (P < 0.01) in catalepsy beha-
viour was observed after 12 weeks in both tests. So, the
catalepsy was developed gradually and it showed maxi-
mum impact after 12 weeks of dichlorvos administration.
Figure 5 Effect of chronic dichlorvos exposure on-Open field behaviour.L o c o m o t o ra c t i v i t y .( B ) .I m m o b i l et i m e( C ) .N o . o fr e a r i n g .( D ) .
Spontaneous locomotor activity (No. of amulations and No. of rearing). (E). Rota rod test. Dichlorvos treated rats received 2.5 mg/kg b.wt. of
dichlorvos, s.c., for 12 weeks and control animals received equal volume of corn oil. The values are mean ± S.D. of 6 animals in each group. * p
< 0.05 significantly different from control group.
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phenotypic markers (TH) and cytoplasmic bodies
containing alpha synuclein and ubiquitin
Nigrostriatal dopaminergic degeneration
(Immunohistochemistry for TH)
Immunohistochemistry of phenotypic marker of dopa-
minergic neurons, TH indicated dopaminergic neurode-
generation (Figure 6A). At 12 weeks of dichlorvos
administration, the number of TH-positive neurons in
the SN was reduced by 60-70% as compared to control
rats (Figure 6B). We found that chronic dichlorvos
administration caused nigral cell loss in rat brain, as
documented by a large decrease in TH-positive neurons
i nt h eS N p ca n dT H - p o s i t i v ef i b e r si nt h eC Sa n dt h i s
was associated with a decline in the levels of dopamine
and dopamine metabolites (DOPAC, HVA) by approxi-
matly 75% (Figure 2C-E). In the next experiment RT-
PCR was performed to confirm the above histochemical
finding.
Expression of tyrosine hydroxylase mRNA in SN and
CS by RT-PCR
In order to confirm the decline in TH positive neurons
(histochemistry result), it was imperative to study the
expression of TH at transcription level by RT-PCR. We
measured the expression of TH mRNA in SN and CS
region after chronic dichlorvos administration. Densito-
metric analysis showed that dichlorvos caused significant
decrease in TH mRNA levels in these regions as com-
pared to control (Figure 6C, D).
Quantitative protein expression of tyrosine hydroxylase
To confirm decrease in TH protein following decrease
in TH-mRNA by dichlorvos exposure, TH protein level
were examined. The TH protein level was examined
(homogenate from SN and CS region) by Western blot-
ting. Densitometric analysis of the bands revealed that
(Figure 6E, F) dichlorvos causes significant decrease in
TH protein expression compared to control. This result
was similar to that of RT-PCR result which also demon-
strated decreased expression of TH at transcription
level.
Effect of chronic dichlorvos exposure on DBH mRNA
expression in SN and CS by RT-PCR
The results described above demonstrated that dichlor-
vos exposure affects TH expression at both the tran-
scription as well as translational levels. Further, we
studied the expression pattern of DBH. It was observed
that chronic dichlorvos administration did not affect the
activity of DBH enzyme. In order to further confirm
these results, we studied the DBH mRNA level by RT-
PCR after chronic dichlorvos administration. Densito-
metric analysis revealed that there was no significant
change in the DBH mRNA levels in SN and CS of trea-
ted animals compared to controls (Figure 6G, H).
Quantitative DBH protein expression in SN and CS of rat
brain after chronic dichlorvos exposure
For the quantitative determination of DBH protein, wes-
tern blot analysis was performed using specific antibody
against DBH in the crude extract prepared from the SN
and CS of control and dichlorvos treated animals. The
crude preparation from SN and CS were probed with
anti-DBH antibody. The microdensitometic analysis of
t h i sw e s t e r nb l o ts h o w e dt h a td i c h l o r v o se x p o s u r ed i d
not show any significant change in the expression of
DBH when compared to controls. Taken together pro-
tein expression, mRNA expression and enzyme activity
of DBH, it is clear that at this dose of dichlorvos, it is
not affecting the adrenergic neurons (Figure 6I, J).
H&E staining and expression of neurofilametary protein
in cortex after chronic dichlorvos exposure
In order to confirm, whether this dose regime of
dichlorvos exposure is affecting other neurons than
dopaminergic neurons, cortical region of control and
treated sections were stained with H&E and neuron spe-
cific neurofilament protein (NFP). These results showed
that, all cortical neurons are intact and there was no
neurodegeneration in cortical region (Figs 7A, B). So, at
this dose it was specifically affecting the dopaminergic
neuron.
a-synuclein and ubiquitin protein aggregates in
substantia nigra after chronic dichlorvos exposure
Nigrostraital neuronal death, cytoplasmic protein aggre-
gates, known as Lewy bodies, containing a-synuclein
and ubiquitin are pathologic hallmarks of PD [15]. Here,
we sought to determine whether there were inclusion
bodies in the SN by staining sections with antibodies
against ubiquitin and a -synuclein. It was observed that
many nigral cells in dichlorvos treated animals demon-
strated a-synuclein positive aggregates along with higher
amount of ubiquitin (Figure 8A-D). Immunofluores-
cence staining was done to confirm the cytoplasmic
inclusions in the cytoplasm of nigral neurons (Figure
8B). No aggregation was seen in the SN region of con-
trol animals. Moreover, this aggregation was specifically
seen only in the SN region of treated animal, as we
were not able to find any aggregation in the hippocam-
pus and CS. The Lewy bodies seen in PD brains contain
ubiquitin in an insoluble form, and chronic in vivo rote-
none exposure also reproduced these ubiquitin-positive
inclusions [3]. Therefore, in order to see if dichlorvos
exposure also caused inclusions of ubiquitin, we esti-
mated ubiquitin in the control and dichlorvos exposed
rats. Immunohistochemistry of treated rat brains
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staining in SN and CS region (Figure 8C, D).
Up-regulation of a-synuclein mRNA following dichlorvos
administration
To determine whether changes in a-synuclein protein
expression are accompanied by changes in a-synuclein
mRNA levels, SN samples from chronic dichlorvos-trea-
ted rat brain were used for semiquantitative RT-PCR
amplification. Other regions, such as the CS and the
hippocampus, were also analyzed. Consistent with a-
synuclein protein alterations, a-synuclein mRNA expres-
sion was increased in the SN following chronic dichlor-
vos exposure. No changes in a-synuclein mRNA
expression were found in either the CS or the hippo-
campus of treated animals (Figure 8E and 8F).
a-synuclein and synaptophysin protein expression after
chronic dichlorvos exposure
To determine whether a-synuclein may be involved in
the deleterious cascade of events induced by dichlorvos,
we also assessed a-synuclein protein expression levels in
the SN, CS and hippocampus of dichlorvos-treated rat
brain. Western blot analysis revealed single band of 19
kDa a-synuclein. After chronic dichlorvos exposure, a-
synuclein protein expression significantly increased only
in SN extracts (Figure 8G, H). No change in a-synuclein
protein level was detected in the CS or in other regions,
Figure 6 Nigrostriatal dopaminergic degeneration. (A) Representative image show TH expression in SN area of dichlorvos treated rat and
control littermate. (B) Bar graph depicts TH-immunoreactive, Cell counts in the SN of dichlorvos rat and control littermate. Values are mean ± S.
D. (N = 6),** p< 0.01 significantly different from control group. (C). Semi quantitative RT-PCR analysis of TH from substantia nigra and corpus
striatum of rat brain. (D) Densitometric analysis of TH/GAPDH. (E). The proteins separated on 10% SDS-PAGE were subjected to immunoblotting
using anti-TH antibody. (F) Densitometric analysis blot. TH/b actin. (G) Effect of chronic dichlorvos exposure on DBH mRNA expression in SN and
CS by RT-PCR (Agarose gel electrophoresis).(H) Densitometric analysis of DBH/GAPDH. (I). Effect of chronic dichlorvos exposure on DBH
quantitative protein expression in substantia nigra and corpus striatum of rat brain. The proteins separated on 12% SDS-PAGE were subjected to
immunoblotting using anti-DBH. (J) Densitometric analysis blot DBH/b actin. Values are mean SD of 4 animals in each group, *p < 0.05
significantly different from control group. Lanes 1,3: Control; Lanes 2,4: Dichlorvos treated; CSN: Control substantia nigra; DSN: Dichlorvos
substantia nigra; CCS: Control corpus striatum; DCS: Dichlorvos corpus striatum.
BK et al. Molecular Brain 2010, 3:35
http://www.molecularbrain.com/content/3/1/35
Page 10 of 20such as hippocampus (Figure 8G, H). In addition to
a-synuclein, levels of synaptophysin, another presynaptic
protein were also estimated so as to ascertain the possi-
bility that a-synuclein alterations might not be a part of
nonspecific response of synaptic-related proteins to
dichlorvos injury. In contrast to changes in a-synuclein
protein levels, b actin and synaptophysin protein levels
remained unchanged in the SN after chronic dichlorvos
administration (Figure 8I, J).
Discussion
Epidemiological studies have repeatedly indicated that
pesticide exposure is a significant risk factor for PD.
However, mechanistic link between increased risk for
PD and chronic exposure to pesticides remains to be
established. Several reports demonstrate modest but
reproducible reductions in mitochondrial complex I
function in a variety of tissues from PD patients, includ-
ing brain, platelets, muscle and fibroblasts. This finding
suggests a systemic complex I defect in PD [3,16,17].
The role of mitochondria in PD has been further accen-
tuated by the observation that MPP+, the active metabo-
lite of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine
(MPTP) and an inhibitor of complex I of the mitochon-
drial electron transport chain (ETC) causes an acute
parkinsonian syndrome [18]. Inhibition of complex I
blocks the flow of electrons along the mitochondrial
electron transport chain, which results in increased
production of ROS. We also observed mitochondrial
complex 1 along with complex 1V inhibition accompa-
nied by increased levels of ROS production after chronic
dichlorvos treatment.
Evidence for the involvement of oxidative stress in PD
has also been obtained from PD patients. Increased lipid
peroxidation and oxidative damage to DNA and proteins
have been observed in SN of PD patients [19]. We also
observed increased lipid peroxidation and increased ROS
levels in SN and CS of chronic dichlorvos treated ani-
mals. Oxidative damage in PD may not be selective to SN
as elevated oxidative protein damage has also been
reported throughout PD brain. Animal models of PD
have also suggested the involvement of oxidative stress.
MPTP-treated mice and dieldrin treated N27 cells
demonstrate elevated levels of ROS and lipid peroxida-
tion [20-22]. These results are in agreement with our
results. Furthermore, the in vitro rotenone model of PD
has also suggested the involvement of oxidative stress in
neurodegenaration [23]. Our results indicate that dichlor-
vos treatment (in vivo) produces marked mitochondrial
and neuritic pathology in the SN. Control animals did
not produce pathologic changes in the SN and CS. The
mitochondrial changes found in this study most likely
reflect the sequelae of injury to mitochondria, but in
addition or alternatively could indicate the involvement
of mitochondria in producing neuronal pathology.
Changes seen in the dichlorvos treated animals are
Figure 7 No neuronal loss occurred in the cortex of dichlorvos exposed animals. (A) Representative H&E image show healthy neuron in
cortex area of dichlorvos treated rat and control littermate. (B) Representative neurofilament protein image show no neuronal loss in cortex area
of dichlorvos treated rat and control littermate.
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treated animal models. Mitochondria from patients with
PD have been described as swollen with rounded rather
than rod-like profiles, to have loss of cristae and to often
have discontinuous outer membranes [24]. Studies in
MPTP-treated animal models have also reported
enlarged mitochondria with disordered mitochondrial
cristae [25]. These finding are strikingly similar to what
we have observed in the SN of our chronic dichlorvos
exposed rats. As dendritic mitochondria tend to be larger
than axonal mitochondria, (noted during our qualitative
comparisons for structural changes), a greater impact on
dendritic mitochondria may also explain the change in
distribution of measurements for the dichlorvos group
relative to the control group that suggests greater effect
on larger mitochondria rather than proportionate
Figure 8 a-synuclein and ubiquitin protein aggregates in SN after chronic dichlorvos exposure. (A) The brain slides were probed with
anti a -synuclein and ubiquitin antibody. The signals were revealed using HRP conjugated secondary antibody and photographed.(B)The brain
slides were probed with anti a -synuclein and ubiquitin antibody. The signals were revealed using FITC conjugated secondary antibody and
photographed. (C and D) The brain slides were probed with anti ubiquitin antibody. The signals were revealed using HRP conjugated secondary
antibody and photographed. (E). Effect of chronic dichlorvos exposure on a -synuclein mRNA expression in SN and CS by RT-PCR.(F)
Densitometric analysis a-synuclein/GAPDH.(G) Effect of chronic dichlorvos exposure on a-synuclein quantitative protein expression in SN and CS
of rat brain. The proteins separated on 10% SDS-PAGE were subjected to immunoblotting using anti a-synuclein antibody. (H). Densitometric
analysis blot a-synuclein/b actin. (I) Effect of chronic dichlorvos exposure on synaptophysin quantitative protein expression in substantia nigra
and corpus striatum of rat brain. The proteins separated on 10% SDS-PAGE were subjected to immunoblotting using anti-synaptophysin
antibody. (J) Densitometric analysis blot synaptophysin/b actin. Values are mean SD of 4 animals in each group, *p < 0.05 significantly different
from control group. Lanes 1,3,5: Control; Lanes 2,4,6: Dichlorvos treated; CSN: control substantia nigra; DSN: Dichlorvos substantia nigra; CCS:
Control corpus striatum; DCS: Dichlorvos corpus striatum; CHC: Control hippocampus; DHC: Dichlorvos hippocampus.
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our mitochondrial measurements were done on all the
mitochondria on each captured EM field of view, the
quantitative changes in the dichlorvos group may also or
instead reflect greater mitochondrial effects on dopami-
nergic neurites independent of whether dendritic or axo-
nal. Dendrites have been demonstrated to be able to
initiate and spread apoptotic cascades to the neuronal
cell body [26] which may form the basis of potential
mechanisms of neurodegeneration. Our findings of, swol-
len and disintegrating mitochondria, autophagic vacuoles
and cytoplasmic shrinkage in dichlorvos exposed animal
SN have all been also observed in the processes of neuro-
nal cell death and in the SN in PD [27]. Further support
of dichlorvos affecting vulnerability to mitochondrial tox-
ins, the pesticide paraquat, and rotenone can inhibit
mitochondrial complex I activity and produce a PD-like
syndrome [3,28].
We observed significant decrease in the dopamine
levels in SN and CS after chronic dichlorvos administra-
tion (Figure 2C-E). Keeping in view the significant dopa-
minergic neuronal death we were interested to study in
detail the dopamine metabolism viz synthetic as well
degradative enzymes leading to altered levels of dopa-
mine after dichlorvos exposure. Although we observed
no change in enzyme activity, protein expression as well
as mRNA level for DBH and Monoamine oxidase A,
after chronic dichlorvos exposure (Figure 6G-J, addi-
t i o n a lf i l e2 ,3 ) .B u ta tt h es a m et i m eT Ha c t i v i t yw a s
significantly decreased after dichlorvos exposure (Figure
2B). Our immunohistochemistry results of TH-positive
neuron counts showed that the number of TH positive
neurons decreased by 84.70 ± 3.4% in the SN of the
dichlorvos exposed animals (Figure 6A and 6B), com-
pared to that in the control group. Likewise, the Wes-
tern blot and RT-PCR results showed there was a
reduction of TH mRNA and protein expression in the
SN and CS of the dichlorvos treated animals (Figure
6C-F). These result confirmed that dichlorvos is acting
at dopamine synthesis stage and not at degradative path-
way. This toxic effect was highly specific to dopaminer-
gic neurons, because cortical neuronal are not affect
(Figure 7). This is also in agreement with findings of
Betarbet et al [3] that systemic rotenone infusion
resulted in nigrostriatal dopaminergic degeneration and
decreased dopamine levels.
It is important to mention that changes in a-synuclein
expression and aggregation after dichlorvos exposure are
region specific because a-synuclein mRNA and protein
expression was increased only in SN and not in other
regions, such as hippocampus and CS. On the other
hand, increased a-synuclein expression does not seem
to be part of a common response of synaptic related
proteins to dichlorvos injury because the expression
levels of synaptophysin, another synapse-associated pro-
tein, were either unchanged or the changes were insig-
nificant after chronic dichlorvos exposure. The
observation that levels of a-synuclein mRNA is also
increased rather supports the view that following
dichlorvos administration a-synuclein is up-regulated
and accumulates in the SN. Altogether, our data raise
the possibility that a-synuclein up-regulation, which
occurs in specific context to dichlorvos-induced apopto-
tic death in SN dopaminergic neurons, contributes to
the cascade of deleterious events that ultimately kill
these cells. Up-regulation of a-synuclein may alter the
normal intracellular trafficking of certain proteins that,
like many of the Bcl-2 family members, depend on
being at a specific intracellular location to exert their
regulatory effects on apoptosis [29,30].
There is also compelling evidence to indicate that
a-synuclein has a significant propensity to aggregate,
and that this property can be enhanced by the familial
PD-linked mutations or by posttranslational modifica-
tions, such as produced by oxidative stress [30-32]. Rele-
vant to this is the fact that a-synuclein is present in
high amounts in the inclusion LB, which is regarded by
some as a key factor in the demise of SNpc dopaminer-
gic neurons in PD. In the dichlorvos exposed rat, we
identify the formation of inclusions in SN region. This
leads to the possibility that a-synuclein up-regulation
may play a role in the dichlorvos-induced neurotoxic
process, through the formation of LB-like inclusions.
We have also found that mitochondrial dysfunctions by
dichlorvos exposure also stimulate production of reactive
oxygen species. Moreover, we have previously reported
that 6 mg/kg of dichlorvos exposure over a period of 12
weeks produces, oxidative damage to proteins and DNA,
and sensitizes cells to subsequent oxidative stressors;
eventually, leading to release of cytochrome c from mito-
chondria to the cytoplasm [11]. This mechanism could
also explain the cytoplasmic inclusions found in nigral
neurons of dichlorvos treated rats, because both oxidative
damage and cytochrome c enhance a-synuclein aggrega-
tion. The recent discovery that an increased level of the
a-synuclein gene resulting from the triplication of a
-synuclein locus causes PD in some individuals and
mutant a-synuclein selectively expressed in astrocyes,
induced rapid progressed paralysis in mice. These data
strongly suggests that over expression and mutation of
this gene could be a risk factor for PD [33,34]. The
a-synuclein over expression due to exposure to environ-
mental pesticides is likely to influence increased vulner-
ability of nigral dopaminergic neurons.
He-Jin Lee et al [35] provided the first cell-based evi-
dence that mitochondrial dysfunction may result in a-
syn aggregation. One of the outcomes of ETC inhibition
is an increased production of free radicals, hence
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groups have shown that the aggregation of a- synuclein
could be promoted by oxidative and nitrative stresses
[36,37]. Indeed, oxidizing and nitrating agents induced
dityrosine cross-linking of recombinant a-synuclein and
stabilized preassembled aggregates [38]. Furthermore,
accumulation of nitrated a- synuclein was demonstrated
in the inclusions of PD, dementia with Lewy bodies,
Lewy body variant of Alzheimer’s disease and multiple
system atrophy, implicating the role of oxidative stress
in LB formation in a-synucleinopathies [39]. We also
observed ETC inhibition, increased ROS production and
oxidative stress after chronic dichlorvos administration
and this may be one of the pathway leading to aggrega-
tion of a- synuclein after dichlorvos exposure. Another
outcome of mitochondrial dysfunction is a defect in
energy production (ATP generation). He-Jin Lee [35]
also showed tight temporal correlations between ATP
level and a- synuclein aggregation both in depletion and
recovery phases, suggesting that an impaired energy
supply may also play a role in a- synuclein aggregation.
This also supports our study, as we observed decreased
ATP production after chronic dichlorvos administration.
Protein aggregation is considered to be a manifesta-
tion of a disturbed cellular protein-folding homeostasis,
which is maintained by at least two defense mechanisms
against damaged (misfolded) proteins: degradation by
the ubiquitin-proteasome (Ub-Pr) system and the cha-
perone-mediated refolding system. Impairment of these
systems, most of which are dependent on ATP, will
cause accumulation of the misfolded proteins. There-
fore, while oxidative stress can increase the rate of pro-
tein misfolding, the concomitant reduction in ATP
levels can decrease the rate at which the cells rescue or
remove the misfolded proteins, thus resulting in protein
aggregates. Interestingly, unlike globular proteins, a-syn
in isolation does not appear to have any stable structure
[40]. To initiate the aggregation process, a-syn has to
undergo a structural transition to form an aggregation-
prone, partially folded intermediate, which is equivalent
to the misfolded proteins in the aggregation process of
globular proteins. In fact, the presence of the partially
folded intermediate and the stabilization of this confor-
mation in the a-syn aggregation process were demon-
strated in recent studies [41,42]. Furthermore, the
degradation of a- synuclein is mediated by the ubiqui-
tin-proteasome system [43,44]. These results suggest
that the aggregation of a-s y n u c l e i nm i g h tb eu n d e r
control of the same defense mechanism as globular pro-
teins. Therefore, the correlation between the ATP level
and a- synuclein aggregation shown in our study sug-
gest that the reduction in energy production, leading to
impaired defense mechanism against misfolded proteins,
is likely to contribute to the aggregation of a- synuclein.
All neurochemical as well as neuropathological
changes seen after dichlorvos exposure seem to be
reflected in the motor functions and catalepsy behavior
of animals. Our results show that dichlorvos treated rats
exhibited a significant reduction in locomotor activity
and rearing frequencies observed in an open field at six
weeks and twelve weeks of exposure. The dichlorvos
exposed animals exhibited significant changes in motor
activity and catalepsy (Figure 5, additional file 5a&b).
This hypokinesia is an important feature of PD and it is
assumed the same might have been produced after
dichlorvos exposure. This result suggests that the lesion
probably produced by a significant destruction of dopa-
minergic neurons of SN (Figure 6A) and consequent
decrease in striatal dopamine levels may cause these
symptoms to appear in our animals. Our study confirms
that dopamine neuronal degeneration leads to decreased
dopamine levels in the SN and CS of dichlorvos exposed
animals and finally culminate in neurobehavioral
impairments
Conclusions
0ur study confirms dopamine neuronal degeneration
and decreased dopamine levels in the SN and CS of
dichlorvos exposed animals. Inspite of ban on dichlorvos
usage by The United States Environmental Protection
Agency in 1981, it continues to be available. This study
high lights that dichlorvos exposure of a low dose and
long duration may be toxic to DA neurons in rats.
Taken together, our results indicate that chronic
dichlorvos exposure may cause nigrostriatal neurodegen-
aration and renewing vents.
Materials and methods
Animals and their care
Male albino Wistar rats (150-200 g) were procured from
the institute animal house and kept in well ventilated
rooms in a 12-h light-dark cycle. Animals were provided
standard rat pellet diet (Hindustan lever Ltd; Mumbai,
India) and water ad libitum. Ethical clearance for killing
of animals was duly obtained from Institute’sA n i m a l
Ethics Committee. The animals were divided into fol-
lowing two groups (6 animals in each group), and four
set of such groups were included in the study, (40 ani-
mals in total were used in whole study).
Control group
Animals received an equal volume of corn oil (vehicle) as
administered to the animals of dichlorvos treated group.
Dichlorvos treated group
Animals received 2.50 mg/kg b.wt./day dichlorvos dis-
solved in corn oil, s.c. for 12 weeks. Three month expo-
sure of rats to dichlorvos is equivalent to almost seven
and half years of human exposure. At this dose regime
acetylcholine esterase activity is not inhibited.
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overnight and sacrificed by decapitation using sodium
pentathol. The brains were removed, rinsed in ice cold
physiological saline (0.9% NaCl) and dissected into fol-
lowing regions: corpus striatum (CS), cortex, hippocam-
pus and substantia nigra (SN) (as per the guidelines of
Paxinos and Watson [45].
Mitochondria from rat brain regions were isolated by
the method of Berman and Hastings [46].
Mitochondrial NADH dehydrogenase (complexes I)
activity
Complexes 1 activity was measured spectrophotometri-
cally by the method of King and Howard [47] as
described previously by Kaur et al [11]. This method
involves catalytic oxidation of NADH to NAD+ with
subsequent reduction of cytochrome c. The reaction
mixture contained 0.2 M glycyl glycine buffer pH 8.5,
6 mM NADH in 2 mM glycyl glycine buffer and 10.5
mM cytochrome c. The reactionwas initiated by addition
of requisite amount of solubilized mitochondrial sample
and followed change in absorbance at 550 nm for 2 min.
Mitochondrial cytochrome oxidase (complex IV) activity)
Cytochrome oxidase activity was assayed in brain mito-
chondria according to the method of Sottocassa et al [48]
described previously by Kaur et al [11]. The assay mix-
ture contained 0.3 mM reduced cytochrome C in 75 mM
phosphate buffer. The reaction was started by the addi-
tion of solubilized mitochondrial sample and change in
absorbance was recorded at 550 nm for 2 min.
ROS generation
Mitochondrial ROS generation was assessed as described
previously by Beretta et al [49] with slight modifications.
Briefly, mitochondria were added to respiration buffer
containing 5 mM pyruvate, 2.5 mM malate and 10 μM
of dichlorodihydrofluorescein diacetate (H2DCFDA).
Fluorescence was quantified after 20 min incubation
using a Cary Eclipse fluorimeter (Varian, Palo Alto,
USA) (excitation 488 nm, emission 525 nm).
Biochemical markers of oxidative stress
Lipid peroxidation
It was assayed by the method of Wills [50]. Mitochon-
drial sample (0.5 ml) was diluted to 1.0 ml using Tris-
HCl buffer (0.1 M, pH 7.4). The reaction mixture was
incubated at 37°C for 2 h with constant shaking. At the
end of the incubation 1.0 ml of TCA (10%, w/v) was
added and then after thorough mixing the reaction mix-
ture was centrifuged at 500 rpm for 10 min. To 1.5 ml
supernatant, 1.5 ml TBA (0.67% w/v) was added and
colour developed by placing the tubes at 100°C for
10 min in a boiling water bath. Samples were cooled
and diluted with 1.0 ml DDW. The results were
expressed as nmol MDA/μg protein.
Antioxidant enzyme assays
Mitochondrial Superoxide Dismutase Assay (SOD)
Mitochondrial superoxide dismutase activity was mea-
sured by the method of MacMillan-Crow et al [51]. Mn-
SOD activity in total solubilized mitochondrial extract
was measured by the cytochrome C reduction method
in the presence of 1 mM potassium cyanide to inhibit
both Cu-Zn SOD and extra cellular SOD. The amount
of enzyme required to produce 50% inhibition was con-
sidered as 1 U of Mn-SOD activity and results were
expressed as U/mg protein.
ATP levels
ATP was determined luminometrically using ATP Biolu-
minescence assay kit (Sigma, St. Louis, MO, USA)
according to the provided protocol. Mitochondrial sam-
ples were assayed for ATP content using the ATP
dependence of the light emitting luciferase-catalyzed
oxidation of luciferin. ATP nanomoles were calculated
using a standard curve and related to protein content
assessed using the method of Lowry.
Estimation of dopamine and its metabolites
The levels of dopamine, 3,4- dihydroxyphenylacetic acid
(DOPAC) and Homovanillic acid (HVA) were measured
by high performance liquid chromatography (HPLC) with
electrochemical detector (ECD) by the method of Gayle
et al [52]. Waters® standard system consisting of a high
pressure isocratic pump, a 20 μls a m p l ei n j e c t o rv a l v e ,C 1 8
reverse phase column and electrochemical detector were
used. Data were recorded and analyzed with the help of
Empower software. Mobile phase consisting of 0.15 M
NaH2PO4, 0.25 mM EDTA, 1.75 mM 1-octane sulfonic
acid, 2% isopropanol and 4% methanol (pH 4.8). Electro-
chemical conditions for the experiment were +0.800 V,
sensitivity ranges from 1 to 100 nA. Separation was carried
out at a flow rate of 1 ml/min. Samples (20 μl) were
injected manually. Brain sections (SN&CS) were homoge-
nized (20%w/v) in homogenizing solution containing
0.1 M perchloric acid. After that samples were centrifuged
at 24,000 × g for 15 min. The supernatant was further fil-
tered through 0.25 μm nylon filters before injecting in the
HPLC injection pump. Data were recorded and analyzed
with the help of Empower® software provided by Waters®.
Concentration of DA, DOPAC and HVA were expressed
as ng/mg was in wet tissue.
Acetylcholinesterase assay
Acetylcholinesterase (AChE) activity was assayed in the
brain homogenates(SN&CS sections) by the method of
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choline to thiocholine and acetate is measured. The
thiocholine reacts with 5,5’-dithiobisnitrobenzoic acid
(DTNB) to give a mixed disulfide and 5-mercapto-2-
nitrobenzoic acid, a yellow compound which was mea-
sured spectrophotometrically at 412 nm.
Tyrosine hydroxylase activity
Tyrosine hydroxylase activity was estimated by the
method of Craine et al [54] and Shiman et al [55]. In a
2.93 ml reaction mix, the final concentrations are
57 mM Tris, 0.3 mM L-tyrosine, 0.2 mM 6,7-dimethyl-
5,6,7,8-tetrahyropterine, 0.15 mM ß-nicotinamide ade-
nine dinucleotide, reduced form, 500 units catalase and
0.5 unit dihydropteridine reductase. 1.0 nanomole of
L-DOPA from tyrosine per minute at pH 7.0 at 37°C.
(one unit).
Dopamine beta hydroxylase (DBH)
The activity of Dopamine b Hydroxylase (DBH) was
assayed by the method of Kato et al [56] which involves
the use of tyramine as the substract. Tyramine is con-
verted to para- hydroxybenzaldehyde, which is isolated
by successive ether extractions followed by ammonia
and the difference between the absorbance at 333 and
360 nm corresponds the DBH activity.
Monoamine oxidase B activity
Monoamine oxidase activity was measured by the
method of McEwen and Cohen [57]. Benzaldehyde pro-
duction from the oxidative deamination of benzylamine
allows a convenient spectrophotometer assay of the
enzyme activity.
Electron microscopy
The dissected brain sections were fixed with 3% glutar-
aldehyde (diluted in 0.2 M Sorenson’sb u f f e rf o r )f o r2 4
h at 4°C. The fixed brain sections were cut into approxi-
mately 1 mm cubes. The cubes were post fixed in 1%
OsO4 for 2 h at 4°C and then dehydrated in an ethanol
series and teated with propylene oxide for 10 min(two
changes) at room temperature. The tissues were infil-
trated with EPON mixture and propylene oxide (1:1) for
2 hr at room temperature and then embedded in EPON
mixture containing Taab/812, followed by polymeriza-
tion at 60°C for 24 hr. 0.5 μm thick sections were cut
using ultra microtome (Reichert-Jung) and stained with
0.5% toluidine blue to confirm the presence of neurons.
Then the 60 nm ultra thin sections were cut and
mounted on Nickel grids (300 mesh). The sections were
double stained with uranyl acetate and lead citrate and
then examined by Transmission Electron Microscope
(ZEISS 906, Germany) and photographed.
Morphological analysis of Mitochondria
Three randomly acquired EM images of the neuropil
from each brain region of interest (SN& CS) from each
animal were photographed, digitally scanned at 600 dots
per inch, and then alphanumerically coded for blinded
analysis. All distinct mitochondria from each image
were outlined by a single trained technician using Scion
Image for Windows to obtain measurements of cross-
sectional area and perimeter for each mitochondrion.
Mitochondria were identified by the presence of both a
distinct double membrane and identifiable cristae. Orga-
nelles that could not be clearly identified as mitochon-
dria were not measured.
Immunohistochemistry of Tyrosine hydroxylase (TH), NFP
and a- synculin
After sacrificing the rat, brain regions (SN, CS and cor-
tex) were isolated and washed with normal saline fol-
lowed by 50 ml of 4% paraformaldehyde in phosphate-
buffered saline (PBS), postfixed in 10% formalin for 5
days, and then paraffin embedded. Paraffin sections
stained with haematoxylin and eosin were examined by
light microscopy. For immunohistochemistry brain sec-
tions (4-5 microns) were cut on poly-L-lysine coated
clean slides. For SN, sections were cut through the
entire SN on a microtome. Every fourth section through
the rostral-caudal extent of the SN was stained with an
antibody against tyrosine hydroxylase. The sections were
fixed overnight at 56°C. To deparaffinize, the slides were
put in oven at 60°C for 2-3 min to melt the wax and
were then put in xylene for 15 min followed by absolute
alcohol for 5 min, 90% alcohol for 5 min, 50% alcohol
for 5 min and finally in distilled water for 5 min. The
slides were dipped in freshly prepared blocking solution
of 1% H2O2 in methanol for 20 min in order to quench
endogenous peroxidase. The washings were given three
times in PBS for 5 min each. The slides were incubated
in respective primary antibodies (anti TH, 1:100;
NFP,1:100/a- syn, 1:150 (santa cruz USA) overnight at
4°C and washings were given three times in PBS for
5 min each. After washing, sections were incubated with
HRP labeled secondary antibody (1:300) for 40 min. Sec-
tions were again washed three times with PBS and cov-
ered with 3,3’-diaminobenzidine (DAB) solution for 10
min at room temperature followed by washing in dis-
tilled water. Sections were then counterstained with hae-
matoxylin and mounted with DPX. Cortex tissue
sections stained by hematoxylin and eosin
Cell count analysis
For quantitative analysis of the TH-positive neurons in
the SN, the midbrain from −4.75 to −5.05 mm anterior
to bregma was cut and the coronal sections were
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intervals between the adjacent sections in each slide.
Among the 5 slides, the adjacent 2 slides were stained for
TH. The counts of TH-positive neurons in SN were per-
formed at a magnification of 20X in each section on both
treated and control animals. Cell numbers are expressed
as the mean number per section from these 10 sections.
For quantitative analysis of the number of SN neurons,
conventional procedures were performed. Neuron den-
sity was measured and averaged from four to six points
of equal site, around which cells were counted within a
100 μm × 100 μma r e ai nt h eS N .O n l yn e u r o n sw i t h
clearly visible nucleoli were counted.
Measurement of locomotor activity
Total locomotor activity (ambulation and rearing) was
measured using a computerized Actophotometer
(IMCORP, India). An array of 16 infrared emitter/detec-
tor pairsmeasured animal activity along a single axis of
motion, the digital data being displayed on the front
panel meter as ambulatory movements. Rats were
allowed to acclimatize to the observation chamber for a
period of 2 min. The activity was monitored continu-
ously for a period of 5 min. Total locomotor activity is
expressed as mean of sum of total ambulatory photo
beam counts and total rearing photo beam counts per
5 min per animal [58].
Motor function test
The effect of dichlorvos on muscle performance was
evaluated using rota-rod apparatus. The speed was set
at 10 rpm and cut off time was 180 s. All rats were
given two initial training trials of 180 s, approximately
10 min apart, to maintain posture on the rota-rod (3 cm
in diameter and rotating at a constant 10 revolutions/
min). After the initial training trials, a baseline trial of
120 s was conducted. The time each animal remained
on the rota- rod was recorded; animals not falling off
the rota-rod were given a maximum score of 180 s [59].
Six weeks and 12 weeks after dichlorvos exposure, rats
were again tested for endurance performance (three
times).
Open field test
Observations were recorded for three test sessions of
5 min each. Mean of test sessions totals of vehicle and
treatment groups ware compared for locomotion (sec-
onds), distance traveled (cm), stereotype events (num-
ber) and rearing (number). Open field test was recorded
automatically by Video Path Analyzer and soft ware
(Anymaze soft ware USA) comprising an open field
chamber (50 · 50 · 35 cm), a video camera fixed over
the chamber. Test was started 10 s after placing the rat
over a black surface at the center of open field chamber.
Measurement of catalepsy by block method
This scoring method followed is in three steps. Step 1:
The rat was taken out of the home cage and placed on
a table. If the rat failed to move when touched or
pushed gently on the back a score of 0.5 was assigned.
Step II: The front paws of the rats were placed alter-
nately on a 3-cm high block. If the rat failed to correct
the posture within 15 seconds, a score of 0.5 for each
paw was added to the score of step 1. Step III: The
front paws of the rat were placed alternately on a 9-cm
high block, if the rat failed to correct the posture within
15 seconds a score of 1 for each paw was added to the
scores of steps I and II. Thus, the highest score for any
animal was 3.5 (cut off score) and that reflects total
catalepsy.
Behavioral assessment by Bar test
Behavioral assessment in dichlorvos induced calaleptic
rat was studied by the method of Kulkarni [60]. Catalep-
tic was measured with a high bar test method. In the
bar test, front paws of the rat were gently placed on a
horizontal metal bar with 5-6 mm diameter and placed
10 cm above ground level and the length of time, the
rats maintained in this abnormal posture with at least
one paw was measured. The test was terminated when
the paw of animal touched the ground or 180 sec had
passed. The total time till which animals stayed on the
bar was recorded. Finally, scores at different time points
(first day, 6
th week, 12
th weeks after dichlorvos treat-
ment) were added and expressed as a cumulative cata-
lepsy score for comparison purposes.
Immunological detection of TH, a- synuclein and
synaptophysin
The samples containing 75 μg protein from SN, Hippo-
campus and CS regions were boiled in laemmli buffer
for 5 min and subjected to electrophoresis (12.5% SDS-
PAGE for alpha synuclein, and 15% SDS-PAGE for TH
and synaptophysin) followed by transfer to a PVDF
membrane. The blots were further blocked with 5%
non-fat dry milk, the membranes were further incubated
with primary anti alpha synuclein/TH antibody/synapto-
physin (1:100 Santa Cruz Biotechnology, C.A, USA) at
room temperature for 2 hrs. After incubation, the PVDF
membranes were washed with PBS plus 0.1% Tween-20
for 30 min, followed by incubation for 1 hr at 37°C with
horseradish peroxidase (HRP) conjugated rabbit anti
rabbit antibody. After 1 hr of incubation, the blots were
again washed with PBS plus 0.1% Tween-20 for 30 min
at 5 min interval of time. Immunoreactive proteins were
visualized by diaminobenzidine (DAB) from Bangalore
Genei. The densitometry analysis of the protein bands
ware carried out using SCION IMAGE software (Scion
Image Corporation, Fredrick, MD, USA) to compare the
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regions of dichlorvos treated as well as control rats.
Immunofluorescence staining of a- synuclein
After sacrificing the rat, brain was isolated, dissected
into different sections and washed with normal saline.
5-6 μm thick frozen sections of brain regions were cut
by microtome. These were then rinsed three times with
phosphate buffer saline (PBS) at 5 min interval. Primary
antibody (1:50) was added and the slides were incubated
for 1 hr at 37°C. Following incubation, the slides were
washed in PBS three times for 5 min each, then the sec-
ondary antibody (FITC labeled) diluted in the ratio of
1:30 was added and the slides were incubated for
30 min at 37°C. Again these were washed three times
for 5 min each in PBS. The slides were then mounted
with glycerol and kept in the dark. Fluorescence was
visualized under a fluorescence microscope and the
images were recorded.
RNA extraction and RT-PCR of TH, DBH and a-synuclein
Total RNA was extracted from different regions of rat
brain by using the RNA extraction kit (Taurus Scientific,
USA) according to manufacturer’s instructions. RNA was
reverse transcribed in a total volume of 20 μl( R e v e r t A i d
cDNA synthesis kit, Fermentas) according to manufac-
turer’s instructions. cDNA products (1 μl) were subjected
to semi quantitative PCR analysis on a gradient thermal
cycler instrument. TH forward (5’-TTCCCCATGTT-
CAACGGACC-3’) and TH reverse (5’ GCGAGCACAG-
TAATCACCTTC-3’). a-synuclein forward (5’TGCT
GTGGATATTGTTGTGG3’) a-synuclein reverse
(5’AGGTGCGGTAGTCTCATGCTC3’)D B Hf o r w a r d
(5’ TTCCCCATGTTCAACGGACC3’)a n dD B Hr e v e r s e
(5’GCGAGCACAGTAATCACCTTC3’) primers ware
used for amplification. GAPDH, which was used as inter-
nal control, was also amplified with GAPDH forward
(5’ CACTGTGCCCATCTATGAGGG3’)a n dG A P D H
reverse (5’TCCACATCTGCTGGAAGGTGG3’) primers.
PCR cycle of TH comprised of initial denaturation at
94°C for 2 min. The amplification was then carried out
for 35 cycles consisting 45 sec each for 94°C (denatura-
tion), 57.5°C (annealing) and 72°C, 1 min (elongation).
Final extension was done at 72°C for 10 min. PCR cycle
of DBH comprised of initial denaturation at 94°C for
2 min. The amplification was then carried out for 35
cycles consisting 45 sec each for 94°C (denaturation),
54.4°C (annealing) and 72°C, 1 min (elongation). Final
extension was done at 72°C for 10 min. For amplification
of a synuclein PCR cycle comprised of initial denatura-
tion at 94°C for 1 min. The amplification was then car-
ried out for 35 cycles at 94°C, 45 sec (denaturation),
58°C, 47.9 s (annealing) and 72°C, 1 min (elongation).
Final extension was done at 72°C for 10 min. GAPDH,
which was used as internal control, was amplified to
determine the densitometric analysis of the products
using SCION IMAGE software (Scion Image Corpora-
tion, Fredrick, MD, USA) to compare the relative mRNA
expression of various genes from different brain regions
of dichlorvos treated and control rats.
Protein determination
Mitochondrial protein was determined by the method of
L o w r ye ta l[ 6 1 ]u s i n gb o v i n es e r u ma l b u m i na s
standard.
Statistical analysis
Data were expressed as mean ± S.D. and statistically sig-
nificant differences between control and treatment were
determined by Student’s t-test.
Additional material
Additional file 1: Effect of chronic dichlorvos exposure on Mn SOD
activity in substantia nigra and corpus striatum of rat brain.
Dichlorvos treated rats received 2.5 mg/kg b.wt of dichlorvos, sc., for 12
weeks and control animals received equal volume of corn oil. The values
are mean ± SD of 6 animals in each group. **P < .0.01, significantly
different from controls SN.*P < .0.05, significantly different from controls
CS. SN: substantia nigra; CS: corpus striatum.
Additional file 2: Effect of chronic dichlorvos exposure on
Dopamine beta hydroxylase activity in substantia nigra and corpus
striatum of rat brain. Dichlorvos treated rats received 2.5 mg/kg b.wt of
dichlorvos, sc., for 12 weeks and control animals received equal volume
of corn oil. The values are mean ± SD of 6 animals in each group. NS-
Non significant. SN: substantia nigra; CS: corpus striatum.
Additional file 3: Effect of chronic dichlorvos exposure on
Monoamine oxidase B activity in substantia nigra and corpus
striatum of rat brain. Dichlorvos treated rats received 2.5 mg/kg b.wt of
dichlorvos, sc., for 12 weeks and control animals received equal volume
of corn oil. The values are mean ± SD of 6 animals in each group. NS-
Non significant.SN: substantia nigra; CS: corpus striatum.
Additional file 4: Effect of chronic dichlorvos exposure on
Acetylcholinesterase activity in substantia nigra and corpus
striatum of rat brain. Dichlorvos treated rats received 2.5 mg/kg b.wt.
of dichlorvos; sc, for 12 weeks and control animals received equal
volume of corn oil. Ns-nonsignificant.
Additional file 5: a&b. Effect of dichlorvos on cataleptic behavior
(Bar test and Block test). Dichlorvos treated rats received 2.5 mg/kg b.
wt. of dichlorvos; sc, for 12 weeks and control animals received equal
volume of corn oil. *p < 0.05 significantly different from control group.
Abbreviations
(PD): Parkinson’s disease; (SNpc): Substantia nigra pars compacta; (DDVP):
dichlorvos; (OP): organophosphate; (ETC): Electron transfer chain; (MPTP): N-
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(DA): dopamine; (HVA): Homovanillic acid.
Acknowledgements
The financial assistance provided to BinuKumar.BK by Indian Council of
Medical Research, New Delhi, India is greatly acknowledged.
BK et al. Molecular Brain 2010, 3:35
http://www.molecularbrain.com/content/3/1/35
Page 18 of 20Author details
1Department of Biochemistry, Postgraduate Institute of Medical Education
and Research, Chandigarh, 160012, India.
2Department of Histopathology,
Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Authors’ contributions
Author contributions: K.D and BK., designed research. BK. performed
research; A.B. analyzed EM data; BK and K.D. prepared the manuscript.R.K
have been involved in drafting the manuscript. All authors read and
approved the final manuscript
Competing interests
The authors declare that they have no competing interests.
Received: 29 September 2010 Accepted: 13 November 2010
Published: 13 November 2010
References
1. Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H,
Przedborski S: NADPH oxidase mediates oxidative stress in the 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. Proc
Natl Acad Sci USA 2003, 100:6145-6150.
2. Baldi I, Cantagrel A, Lebailly P, Tison F, Dubroca B, Chrysostome V,
Dartigues JF, Brochard P: Association between Parkinson’s disease and
exposure to pesticides in southwestern France. Neuroepidemiology 2003,
22:305-10.
3. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV,
Greenamyr JT: Chronic systemic pesticide exposure reproduces features
of Parkinson’s disease. Nat Neurosci 2003, 12:1301-1306.
4. Hertzman C, Wiens M, Snow MB, Kelly SA: Case-control study of
Parkinson’s disease in a horticultural region of British Columbia. Mov
Disorder 1994, 9:69-75.
5. Tanner CM: The role of environmental toxins in the etiology of
Parkinson’s disease. Trends in Neuroscience 1989, 12:49-54.
6. Li SC, Schoenberg BS, Wang CC, Cheng XM, Rui DY, Bolis CL: A prevalence
survey of Parkinson’s disease and other movement disorders in the
People’s Republic of China. Arch Neurol 1985, 42:655-657.
7. Tanner CM, Chen B, Wang W: Environmental factors and Parkinson’s
disease: a case control-study in China. Neurology 1989, 39:660-664.
8. Ho S, Woo J, Lee C: Epidemiologic study of Parkinson’s disease in Hong
Kong. Neurology 1989, 39:1314-18.
9. McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Cory-
Slechta DA, Di Monte DA: Environmental risk factors and Parkinson’s
disease: selective degeneration of nigral dopaminergic neurons caused
by the herbicide paraquat. Neurobiol Dis 2002, 10:119-127.
10. Allam MF, Del Castillo AS, Navajas RF: Parkinson’s disease risk factors:
genetic, environmental, or both? Neurol Res 2005, 27:206-208.
11. Kaur P, Radotra B, Minz RW, Gill KD: Impaired mitochondrial energy
metabolism and neuronal apoptotic cell death after chronic dichlorvos
(OP) exposure in rat brain. Neurotoxicology 2007, 28:1208-1219.
12. Binukumar BK, Bal A, Kandimalla R, Sunkaria A, Gill KD: Mitochondrial
energy metabolism impairment and liver dysfunction following chronic
exposure to dichlorvos. Toxicology 2010, 270:77-84.
13. Choudhary S, Raheja G, Gupta V, Gill KD: Possible involvement of
dopaminergic neurotransmitter system in dichlorvos induced delayed
neurotoxicity. J Biochem Mol Biol Biophys 2002, 6:29-36.
14. Luty S, Latuszynska J, Halliop J, Tochman A, Obuchowska D, Przylepa E,
Korczak E, Bychawski E: Toxicity of dermally absorbed dichlorvos in rats.
Ann Agric Environ Med 1998, 5:57-64.
15. Ma QL, Chan P, Yoshii M, Uéda K: Alpha-synuclein aggregation and
neurodegenerative diseases. J Alzheimers Dis 2003, 5(2):139-48.
16. Izuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T: Deficiencies in
complex I subunits of the respiratory chain in Parkinson’s disease.
Biochem Biophys Res Commun 1989, 163:1450-5.
17. Parker WD, Boyson SJ, Parks JK: Abnormalities of the electron transport
chain in idiopathic Parkinson’s disease. Ann Neurol 1989, 26:719-23.
18. Javitch JA, D’Amato RJ, Strittmatter SM, Snyder SH: Parkinsonism-inducing
neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the
metabolite N-methyl-4-phenylpyridine by dopamine neurons explains
selective toxicity. Proc Natl Acad Sci USA 1985, 82:2173-2173.
19. Olanow CW, Jenner P, Tatton N, Tatton WG: Neurodegeneration in
Parkinson’s disease. In Parkinson’s Disease and Movement Disorders.. 3
edition. Edited by: Jankovic J, Tolosa E. Baltimore, MD: Williams
1988:67-103.
20. Sriram K, Pai KS, Boyd MR, Ravindranath V: Evidence for generation of
oxidative stress in brain by MPTP: in vitro and in vivo studies in mice.
Brain Res 1997, 749:44-52.
21. Matthews RT, Klivenyi P, Mueller G, Yang L, Wermer M, Thomas CE, Beal MF:
Novel free radical spin traps protect against malonate and MPTP
neurotoxicity. Exp Neurol 1997, 157:120-126.
22. Kanthasamy AG, Kitazawa M, Yang Y, Anantharam V, Kanthasamy A:
Environmental neurotoxin dieldrin induces apoptosis via caspase-3-
dependent proteolytic activation of protein kinase C delta (PKCdelta):
Implications for neurodegeneration in Parkinson’s disease. Mol Brain
2008, 1:12.
23. Sherer TB, Betarbet R, Greenamyre JT: Environment, mitochondria, and
Parkinson’s disease. J Neuroscientist 2002, 8:192-97.
24. Trimmer PA, Swerdlow RH, Parks JK, Keeney P, Bennett JP, Miller SW,
Davis RE, Parker WD: Abnormal mitochondrial morphology in sporadic
Parkinson’s and Alzheimer’s disease cybrid cell lines. Exp Neurol 2000,
162:37-50.
25. Levi AC, Ravazzani R, de Mattei M: Mitochondrial abnormalities in nigral
neurons of the marmoset and Macaca fascicularis treated with MPTP.
Panminerva Med 1994, 36:53-56.
26. Duan W, Rangnekar VM, Mattson MP: Prostate apoptosis response-4
production in synaptic compartments following apoptotic and
excitotoxic insults: evidence for a pivotal role in mitochondrial
dysfunction and neuronal degeneration. J Neurochem 1999, 72:2312-2322.
27. Anglade P, Vyas S, Hirsch EC, Agid Y: Apoptosis in dopaminergic neurons
of the human substantia nigra during normal aging. Histol Histopathol
1997, 12:603-6010.
28. Barbeau A, Roy M, Cloutier T, Plasse L: Environmental and genetic factors
in the etiology of Parkinson’s disease. In Advances in Neurology. Volume
45. Edited by: Yahr, Bergmann. New York: Raven Press; 1986:299-306.
29. Merry DE, Korsmeyer SJ: Bcl-2 gene family in the nervous system. Annu
Rev Neurosci 1997, 20:245-67.
30. Kanda S, Bishop JF, Eglitis MA, Yang Y, Mouradian MM: Enhanced
vulnerability to oxidative stress by alpha-synuclein mutations and C-
terminal truncation. Neuroscience 2000, 97(2):279-84.
31. El-Agnaf OM, Jakes R, Curran MD, Wallace A: Effects of the mutations
Ala30 to Pro and Ala53 to Thr on the physical and morphological
properties of alpha-synuclein protein implicated in Parkinson’s disease.
FEBS Lett 1998, 440(1-2):67-70.
32. Qiao L, Hamamichi S, Caldwell KA, Caldwell GA, Yacoubian TA, Wilson S,
Xie ZL, Speake LD, Parks R, Crabtree D, Liang Q, Crimmins S, Schneider L:
Lysosomal enzyme cathepsin D protects against alpha-synuclein
aggregation and toxicity. Mol Brain 2008, 1:17.
33. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S: alpha-Synuclein
locus triplication causes Parkinson’s disease. Science 2003, 302(5646):841.
34. Gu XL, Long CX, Sun L, Xie C, Lin X, Cai H: Astrocytic expression of
Parkinson’s disease-related A53T alpha-synuclein causes
neurodegeneration in mice. Mol Brain 2010, 3:12.
35. He-Jin Lee, Chan Choi, Seung-Jae Lee: Membrane-bound alpha-Synuclein
Has a High Aggregation Propensity and the Ability to Seed the
Aggregation of the Cytosolic Form. J Biochem 2002, 277(1):671-678.
36. Hashimoto M, Hsu LJ, Xia Y, Takeda A, Sisk A, Sundsmo M, Masliah E:
Oxidative stress induces amyloid-like aggre- gate formation of NACP/
alpha-synuclein in vitro. Neuroreport 1999, 10:717-21.
37. Paxinou E, Chen Q, Weisse M, Giasson BI, Norris EH, Rueter SM,
Trojanowski JQ, Lee VM, Ischiropoulos HJ: Induction of alpha-synuclein
aggregation by intracellular nitrative insult. Neurosci 2001, 21:8053-61.
38. Souza JM, Giasson BI, Chen Q, Lee VM, Ischiropoulos H: Dityrosine cross-
linking promotes formation of stable alpha -synuclein polymers.
Implication of nitrative and oxidative stress in the pathogenesis of
neurodegenerative synucleinopathies. J Biol Chem 2000, 275:18344-49.
39. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI,
Ischiropoulos H, Trojanowski JQ, Lee VM: Oxidative damage linked to
neurodegeneration by selective alpha- synuclein nitration in
synucleinopathy lesions. Science 2000, 290:985-89.
BK et al. Molecular Brain 2010, 3:35
http://www.molecularbrain.com/content/3/1/35
Page 19 of 2040. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT: NACP a protein
implicated in Alzheimer’s disease and learning, is natively unfolded.
Biochemistry 1996, 35:13709-715.
41. Uversky VN, Lee H J, Li J, Fink AL, Lee SJ: Stabilization of partially folded
conformation during alpha-synuclein oligomerization in both purified
and cytosolic preparations. J BiolChem 2001, 276:43495-43498.
42. Uversky VN, Li J, Fink AL: Evidence for a partially folded intermediate in
alpha-synuclein fibril formation. J Biol Chem 2001, 276:10737-744.
43. Bennett MC, Bishop JF, Leng Y, Chock PB, Chase TN, Mouradian MM:
Degradation of alpha-synuclein by proteasome. J Biol Chem 1999,
274:33855-58.
44. Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A,
Schneider R, Mizuno Y, Kosik KS, Selkoe DJ: Ubiquitination of a new form
of alpha-synuclein by parkin from human brain: implications for
Parkinson’s disease. Science 2001, 293:263-269.
45. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. Academic
Press, London; 1986.
46. Berman SB, Hastings TG: Dopamine oxidation alters mitochondrial
respiration and induces permeability transition in brain mitochondria:
implications for Parkinson’s disease. J Neurochem 1997, 73:1127-1137.
47. King TE, Howard RL: Preparation and properties of soluble NADH
dehydrogenase from cardiac muscle.Edited by: Colowick SP, Kaplan NO.
Methods in Enzymology. Acad. Press, New York; 1967:275-276.
48. Sottocassa GL, Kuylenstierna B, Ernster L, Bergstrand A: An electron
transport system associated with the outer membrane of liver
mitochondria. J Cell Biol 1967, 32:415-438.
49. Beretta S, Sala G, Mattavelli L, Ceresa C, Casciati A, Ferri A, Carrì MT,
Ferrarese C: Mitochondrial dysfunction due to mutant copper/zinc
superoxide dismutase associated with amyotrophic lateral sclerosis is
reversed by N-acetylcysteine. Neurobiol Dis 2003, 13:213-221.
50. Wills ED: Mechanisms of lipid peroxide formation in animal tissues. J
Biochem 1966, 99:667-676.
51. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA:
Nitration and inactivation of manganese superoxide dismutase in
chronic rejection of human renal allografts. Proc Natl Acad Sci USA 1966,
93:11853-11858.
52. Gayle DA, Ling Z, Tong C, Landers T, Lipton JW, Carvey PM:
Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of
tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res
Dev Brain Res 2002, 133:27-35.
53. Ellman GL, Courtney KD, Andres VJR, Feather-Stone RM: A new and rapid
colorimetric determination of acetylcholinesterase activity. Biochem
Pharmacol 1961, 7:88-95.
54. Craine JE, Hall ES, Kaufman S: The isolation and characterization of
dihydropteridine reductase from sheep liver. J Biol Chem 1972,
247:6082-91.
55. Shiman R, Akino M, Kaufman S: Solubilization and partial purification of
tyrosine hydroxylase from bovine adrenal medulla. J Biol Chem 1971,
246:1330-40.
56. Kato T, Nagatsu T, Hashimoto Y, Numata-Sudo Y, Yamori Y, Okamoto K:
Dopamine beta-hydroxylase activity in stroke-prone spontaneously
hypertensive rats. Jpn Heart J 1978, 19(4):641.
57. Mcewen , Cohen JD: An amine oxidase innormal human serum. J Lab Clin
Med 1963, 62:766-76.
58. Bishnoi M, Chopra K, Kulkarni SK: Involvement of adenosinergic receptor
system in an animal model of tardive dyskinesia and associated
behavioural, biochemical and neurochemical changes. Eur J Pharmacol
2006, 552:55-66.
59. Kulkarni SK: Handbook of Experimental Pharmacology. Vallabh Prakashan,
Delhi;, 3 1999.
60. Kulkarni SK, Anil Kumar S: Effect of BR-16A (Mentat®), a poly herbal
formulation on drug induced catalepsy in mice. Ind J Exp Biol 2006,
44:45-48.
61. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with
the folin-phenol reagent. J Biol Chem 1951, 193:265-75.
doi:10.1186/1756-6606-3-35
Cite this article as: BK et al.: Nigrostriatal neuronal death following
chronic dichlorvos exposure: crosstalk between mitochondrial
impairments, a synuclein aggregation, oxidative damage and
behavioral changes. Molecular Brain 2010 3:35.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
BK et al. Molecular Brain 2010, 3:35
http://www.molecularbrain.com/content/3/1/35
Page 20 of 20